PECAM1 and hematologic disorder: A previous review indicated that platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) is involved in inhibiting apoptosis and thus contributes to resistance to chemotherapeutic treatment in various types of tumors, including hematologic malignancies [22].